PEMBROKE, Bermuda--(BUSINESS WIRE)--Covidien Ltd. (NYSE: COV; BSX: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), has priced an offering of $2.75 billion aggregate principal amount of fixed rate senior notes to qualified institutional buyers pursuant to Rule 144A of the Securities Act of 1933 (the "Securities Act") and to non-U.S. persons in reliance on Regulation S under the Securities Act.
